Home › Funds › Millennium Management › CHRS
Millennium Management position in CHRS
COHERUS ONCOLOGY INC · Health Care
Latest position (Q2 2026)20.75K sh
Reported value held$29.05K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 484.02K | $7.78M | New |
| Q4 2021 | 330.44K | $5.27M | Reduce |
| Q1 2022 | 202.06K | $2.61M | Reduce |
| Q2 2022 | 389.31K | $2.82M | Add |
| Q3 2022 | 517.15K | $4.97M | Add |
| Q4 2022 | 542.62K | $4.30K | Add |
| Q1 2023 | 218.47K | $1.49K | Reduce |
| Q2 2023 | 852.47K | $3.64M | Add |
| Q3 2023 | 216.68K | $810.38K | Reduce |
| Q4 2023 | 2.84M | $9.46M | Add |
| Q1 2024 | 1.26M | $3.01M | Reduce |
| Q2 2024 | 616.03K | $1.07M | Reduce |
| Q3 2024 | 797.51K | $829.41K | Add |
| Q4 2024 | 1.05M | $1.45M | Add |
| Q1 2025 | 2.90M | $2.34M | Add |
| Q2 2025 | 1.38M | $1.01M | Reduce |
| Q4 2025 | 660.45K | $937.84K | New |
| Q1 2026 | 311.99K | $527.26K | Reduce |
| Q2 2026 | 20.75K | $29.05K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CHRS
- BlackRock Inc 12.00M sh · $16.80M · Q2 2026
- Vanguard Group 10.03M sh · $14.24M · Q4 2025
- Geode Capital Management 3.69M sh · $5.16M · Q2 2026
- Two Sigma Investments 2.26M sh · $3.16M · Q2 2026
- AQR Capital Management 1.33M sh · $1.86M · Q2 2026
- Charles Schwab Investment Management 1.23M sh · $1.72M · Q2 2026
- Northern Trust Corp 1.13M sh · $1.58M · Q2 2026
- UBS Group AG 760.36K sh · $1.06M · Q2 2026
- Goldman Sachs Group 602.08K sh · $842.90K · Q2 2026
- Renaissance Technologies 563.06K sh · $788.28K · Q2 2026
- Invesco Ltd 353.92K sh · $495.49K · Q2 2026
- BNY Mellon 319.69K sh · $447.56K · Q2 2026